Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele
  2. Graveel, C.; Su, Y. L.; Koeman, J.; Wang, L. M.; Tessarollo, L.; Fiscella, M.; Birchmeier, C.; Swiatek, P.; Bronson, R.; Woude, G. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004, DEC 7; 101(49): 17198-17203.
  1. 2.   Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome
  2. Nickerson, M. L.; Warren, M. B.; Toro, J. R.; Matrosova, V.; Glenn, G.; Turner, M. L.; Duray, P.; Merino, M.; Choyke, P.; Pavlovich, C. P.; Sharma, N.; Walther, M.; Munroe, D.; Hill, R.; Maher, E.; Greenberg, C.; Lerman, M. I.; Linehan, W. M.; Zbar, B.; Schmidt, L. S.
  3. Cancer Cell. 2002 2(2): 157-164.
  1. 3.   Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
  2. Danilkovitch-Miagkova, A.; Zbar, B.
  3. Journal of Clinical Investigation. 2002 109(7): 863-867.
  1. 4.   Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods
  2. Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2001 17(3): 210-219.
  1. 5.   Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies
  2. Miller, M.; Ginalski, K.; Lesyng, B.; Nakaigawa, N.; Schmidt, L.; Zbar, B.
  3. Proteins-Structure Function and Genetics. 2001 44(1): 32-43.
  1. 6.   A novel germ line juxtamembrane Met mutation in human gastric cancer
  2. Lee, J. H.; Han, S. U.; Cho, H.; Jennings, B.; Gerrard, B.; Dean, M.; Schmidt, L.; Zbar, B.; Vande Woude, G. F.
  3. Oncogene. 2000 19(43): 4947-4953.
  1. 7.   Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src
  2. Nakaigawa, N.; Weirich, G.; Schmidt, L.; Zbar, B.
  3. Oncogene. 2000 19(26): 2996-3002.
  1. 8.   Signature-based analysis of MET proto-oncogene mutations using DHPLC
  2. Nickerson, M. L.; Weirich, G.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2000 16(1): 68-76.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel